Regulatory mechanisms controlling human E-cadherin gene expression

Yan Nan Liu, Wen Wen Lee, Chun Yi Wang, Tung Hui Chao, Yvan Chen, Hshiung Chen Ji

Research output: Contribution to journalArticle

136 Citations (Scopus)

Abstract

In cancer cells, loss of E-cadherin gene expression caused dysfunction of the cell-cell junction system, triggering cancer invasion and metastasis. Therefore, E-cadherin is an important tumor-suppressor gene. To understand how E-cadherin gene expression is regulated in cancer cells, we have used E-cadherin-positive and -negative expressing cells to find out the possible up- or downregulating transcription factors in human E-cadherin regulatory sequences. Functional analysis of human E-cadherin regulatory sequences constructs indicated that AML1, Sp1, and p300 may play important roles in promoting E-cadherin expression. In addition, we found there are four HNF3-binding sites in human E-cadherin regulatory sequences. The exogenous HNF3 can enhance the E-cadherin promoter activity in metastatic breast cancer cells and the metastatic breast cancer cells stably transfected with HNF3 showed re-expression of E-cadherin. The HNF3 stable transfectants changed from mesenchymal-like into epithelial morphology. The trans-well assays showed the re-expressed E-cadherin reduced cell motility of metastatic breast cancer cells. These results suggested HNF3 may play important roles in the upregulation of the E-cadherin promoter, with the consequent re-expression of E-cadherin, thus reducing the metastatic potential of breast cancer cells. These findings suggested HNF3 plays important roles in the upregulation of the E-cadherin gene and may be able to reduce the motility of metastatic breast cancer cells.

Original languageEnglish
Pages (from-to)8277-8290
Number of pages14
JournalOncogene
Volume24
Issue number56
DOIs
Publication statusPublished - Dec 15 2005
Externally publishedYes

Fingerprint

Cadherins
Gene Expression
Breast Neoplasms
Up-Regulation
Neoplasms
Intercellular Junctions
Tumor Suppressor Genes
Cell Movement
Transcription Factors
Down-Regulation
Binding Sites

Keywords

  • E-cadherin
  • Gene expression
  • HNF3 (Hepatocyte Nuclear Factor)
  • Metastasis

ASJC Scopus subject areas

  • Molecular Biology
  • Cancer Research
  • Genetics

Cite this

Liu, Y. N., Lee, W. W., Wang, C. Y., Chao, T. H., Chen, Y., & Ji, H. C. (2005). Regulatory mechanisms controlling human E-cadherin gene expression. Oncogene, 24(56), 8277-8290. https://doi.org/10.1038/sj.onc.1208991

Regulatory mechanisms controlling human E-cadherin gene expression. / Liu, Yan Nan; Lee, Wen Wen; Wang, Chun Yi; Chao, Tung Hui; Chen, Yvan; Ji, Hshiung Chen.

In: Oncogene, Vol. 24, No. 56, 15.12.2005, p. 8277-8290.

Research output: Contribution to journalArticle

Liu, YN, Lee, WW, Wang, CY, Chao, TH, Chen, Y & Ji, HC 2005, 'Regulatory mechanisms controlling human E-cadherin gene expression', Oncogene, vol. 24, no. 56, pp. 8277-8290. https://doi.org/10.1038/sj.onc.1208991
Liu, Yan Nan ; Lee, Wen Wen ; Wang, Chun Yi ; Chao, Tung Hui ; Chen, Yvan ; Ji, Hshiung Chen. / Regulatory mechanisms controlling human E-cadherin gene expression. In: Oncogene. 2005 ; Vol. 24, No. 56. pp. 8277-8290.
@article{334932d95d6c46eba23f6561ca5bb43f,
title = "Regulatory mechanisms controlling human E-cadherin gene expression",
abstract = "In cancer cells, loss of E-cadherin gene expression caused dysfunction of the cell-cell junction system, triggering cancer invasion and metastasis. Therefore, E-cadherin is an important tumor-suppressor gene. To understand how E-cadherin gene expression is regulated in cancer cells, we have used E-cadherin-positive and -negative expressing cells to find out the possible up- or downregulating transcription factors in human E-cadherin regulatory sequences. Functional analysis of human E-cadherin regulatory sequences constructs indicated that AML1, Sp1, and p300 may play important roles in promoting E-cadherin expression. In addition, we found there are four HNF3-binding sites in human E-cadherin regulatory sequences. The exogenous HNF3 can enhance the E-cadherin promoter activity in metastatic breast cancer cells and the metastatic breast cancer cells stably transfected with HNF3 showed re-expression of E-cadherin. The HNF3 stable transfectants changed from mesenchymal-like into epithelial morphology. The trans-well assays showed the re-expressed E-cadherin reduced cell motility of metastatic breast cancer cells. These results suggested HNF3 may play important roles in the upregulation of the E-cadherin promoter, with the consequent re-expression of E-cadherin, thus reducing the metastatic potential of breast cancer cells. These findings suggested HNF3 plays important roles in the upregulation of the E-cadherin gene and may be able to reduce the motility of metastatic breast cancer cells.",
keywords = "E-cadherin, Gene expression, HNF3 (Hepatocyte Nuclear Factor), Metastasis",
author = "Liu, {Yan Nan} and Lee, {Wen Wen} and Wang, {Chun Yi} and Chao, {Tung Hui} and Yvan Chen and Ji, {Hshiung Chen}",
year = "2005",
month = "12",
day = "15",
doi = "10.1038/sj.onc.1208991",
language = "English",
volume = "24",
pages = "8277--8290",
journal = "Oncogene",
issn = "0950-9232",
publisher = "Nature Publishing Group",
number = "56",

}

TY - JOUR

T1 - Regulatory mechanisms controlling human E-cadherin gene expression

AU - Liu, Yan Nan

AU - Lee, Wen Wen

AU - Wang, Chun Yi

AU - Chao, Tung Hui

AU - Chen, Yvan

AU - Ji, Hshiung Chen

PY - 2005/12/15

Y1 - 2005/12/15

N2 - In cancer cells, loss of E-cadherin gene expression caused dysfunction of the cell-cell junction system, triggering cancer invasion and metastasis. Therefore, E-cadherin is an important tumor-suppressor gene. To understand how E-cadherin gene expression is regulated in cancer cells, we have used E-cadherin-positive and -negative expressing cells to find out the possible up- or downregulating transcription factors in human E-cadherin regulatory sequences. Functional analysis of human E-cadherin regulatory sequences constructs indicated that AML1, Sp1, and p300 may play important roles in promoting E-cadherin expression. In addition, we found there are four HNF3-binding sites in human E-cadherin regulatory sequences. The exogenous HNF3 can enhance the E-cadherin promoter activity in metastatic breast cancer cells and the metastatic breast cancer cells stably transfected with HNF3 showed re-expression of E-cadherin. The HNF3 stable transfectants changed from mesenchymal-like into epithelial morphology. The trans-well assays showed the re-expressed E-cadherin reduced cell motility of metastatic breast cancer cells. These results suggested HNF3 may play important roles in the upregulation of the E-cadherin promoter, with the consequent re-expression of E-cadherin, thus reducing the metastatic potential of breast cancer cells. These findings suggested HNF3 plays important roles in the upregulation of the E-cadherin gene and may be able to reduce the motility of metastatic breast cancer cells.

AB - In cancer cells, loss of E-cadherin gene expression caused dysfunction of the cell-cell junction system, triggering cancer invasion and metastasis. Therefore, E-cadherin is an important tumor-suppressor gene. To understand how E-cadherin gene expression is regulated in cancer cells, we have used E-cadherin-positive and -negative expressing cells to find out the possible up- or downregulating transcription factors in human E-cadherin regulatory sequences. Functional analysis of human E-cadherin regulatory sequences constructs indicated that AML1, Sp1, and p300 may play important roles in promoting E-cadherin expression. In addition, we found there are four HNF3-binding sites in human E-cadherin regulatory sequences. The exogenous HNF3 can enhance the E-cadherin promoter activity in metastatic breast cancer cells and the metastatic breast cancer cells stably transfected with HNF3 showed re-expression of E-cadherin. The HNF3 stable transfectants changed from mesenchymal-like into epithelial morphology. The trans-well assays showed the re-expressed E-cadherin reduced cell motility of metastatic breast cancer cells. These results suggested HNF3 may play important roles in the upregulation of the E-cadherin promoter, with the consequent re-expression of E-cadherin, thus reducing the metastatic potential of breast cancer cells. These findings suggested HNF3 plays important roles in the upregulation of the E-cadherin gene and may be able to reduce the motility of metastatic breast cancer cells.

KW - E-cadherin

KW - Gene expression

KW - HNF3 (Hepatocyte Nuclear Factor)

KW - Metastasis

UR - http://www.scopus.com/inward/record.url?scp=32844465287&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=32844465287&partnerID=8YFLogxK

U2 - 10.1038/sj.onc.1208991

DO - 10.1038/sj.onc.1208991

M3 - Article

C2 - 16116478

AN - SCOPUS:32844465287

VL - 24

SP - 8277

EP - 8290

JO - Oncogene

JF - Oncogene

SN - 0950-9232

IS - 56

ER -